Compare Canadian Pacific Kansas City Limited Common Shares (CP) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canadian Pacific Kansas City Limited Common Shares vs Inovio Pharmaceuticals Inc — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $84.07 (market cap $73.98B), while Inovio Pharmaceuticals Inc trades at $1.09 (market cap $112.19M). The key difference: Canadian Pacific Kansas City Limited Common Shares is far larger — about 659.4× Inovio Pharmaceuticals Inc's market cap, and Canadian Pacific Kansas City Limited Common Shares pays a 0.9% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CP | INO | |
|---|---|---|
Market Cap | $73.98B | $112.19M |
Volume | 1,669,828 | 3,201,278 |
Sector | Industrials | Health |
52-Week High | $96.69 | $2.65 |
52-Week Low | $68.88 | $0.66 |
Enterprise Value | $91.36B | $83.51M |
Dividend Yield | 0.9% | — |
Typical Hold Time | — | 43 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Inovio Pharmaceuticals trades at $1.155, up 2.21% today, with a bearish technical signal despite recent earnings beats. The company faces significant fundamental challenges with minimal revenue of $65,340 and substantial losses, reflected in a -130,000% net margin. Key catalyst is the October 30, 2026 FDA decision on INO-3107 for recurrent respiratory papillomatosis, with analyst consensus leaning bullish at a $2.75 price target.
Investment outlook hinges on FDA approval success; upside exists if INO-3107 gains approval, but persistent cash burn and lack of commercial revenue pose substantial risks. The stock remains speculative with high volatility expected around regulatory milestones.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Canadian Pacific Kansas City Limited Common Shares
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
